Top Markets
#1 Pleasing Gold Pleasing Gold +1,502.41%
#2 PulseChain PulseChain +58.12%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.03%
#4 BOOK OF MEME BOOK OF MEME +27.49%
#5 Ontology Gas Ontology Gas +27.07%
#6 Pump.fun Pump.fun +24.18%
#7 Unit Pump Unit Pump +23.05%
#8 Nockchain Nockchain +22.70%
#9 ConstitutionDAO ConstitutionDAO +21.16%
#10 Neiro Neiro +20.80%
Coin of the day
Pleasing Gold Pleasing Gold
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Ambalal Sarabhai Enterprises Limited Ambalal Sarabhai Enterprises Limited

Ambalal Sarabhai Enterprises Limited

AMBALALSA
Rangering i aksjer #26488
Ambalal Sarabhai Enterprises Ltd. operates as a holding company with... Ambalal Sarabhai Enterprises Ltd. operates as a holding company with investments across the pharmaceutical and electrical industries. Its core activities include the production and marketing of pharmaceutical goods. The company was established on June 27, 1977, and its principal office is located in Ahmedabad, India.
Aksjekurs
$0.52431453
Markedsverdi
$40.18M
Endring (1 dag)
2.15%
Endring (1 år)
33.33%
Land
IN
Handel Ambalal Sarabhai Enterprises Limited (AMBALALSA)

Kategori

Healthcare
Inntekter for Ambalal Sarabhai Enterprises Limited (AMBALALSA)
Inntekter i 2026 TTM: 0
Ifølge Ambalal Sarabhai Enterprises Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Ambalal Sarabhai Enterprises Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT